Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Johnson & Johnson
(NY:
JNJ
)
240.40
+0.77 (+0.32%)
Official Closing Price
Updated: 7:00 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,179,793
Open
238.12
Bid (Size)
238.60 (100)
Ask (Size)
240.30 (500)
Prev. Close
239.63
Today's Range
235.43 - 240.79
52wk Range
141.50 - 251.71
Shares Outstanding
2,628,679,824
Dividend Yield
2.16%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Johnson & Johnson (NYSE:JNJ): A Dividend King Built for Sustainable Passive Income
↗
Today 7:31 EST
Via
Chartmill
FDA Clears Johnson & Johnson's Multiple Myeloma Combo Drug After Strong Survival Results
↗
March 06, 2026
FDA approves Johnson & Johnson's Tecvayli with Darzalex Faspro for multiple myeloma after strong Phase 3 survival results.
Via
Benzinga
Performance
YTD
+15.9%
+15.9%
1 Month
+1.1%
+1.1%
3 Month
+19.2%
+19.2%
6 Month
+35.0%
+35.0%
1 Year
+44.2%
+44.2%
More News
Read More
Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion
March 05, 2026
Via
FinancialNewsMedia
2 Top Defensive ETFs That Prioritize Stability Over Excitement
↗
March 04, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
World Trade
ImmunityBio (IBRX) Shares Plummet Despite Piper Sandler Price Target Hike and 700% Revenue Growth
March 04, 2026
Via
MarketMinute
Topics
Earnings
Economy
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
March 04, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
March 02, 2026
From
Johnson & Johnson
Via
Business Wire
How to Spot Winning Innovation
↗
March 02, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Middleby Is Spinning Off Its Food Processing Segment After a $540 Million Asset Sale. Can the Breakup Close Its Valuation Gap?
↗
February 28, 2026
Via
The Motley Fool
2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash
↗
February 27, 2026
Via
The Motley Fool
Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability
February 26, 2026
Via
Finterra
Topics
Earnings
Economy
Intellectual Property
ACR Alpine Capital Research Buys 1 Million Shares of Arrow Electronics Stock
↗
February 25, 2026
Via
The Motley Fool
Boring Is Beautiful: Why Johnson & Johnson Is Beating the Tech Sector
↗
February 24, 2026
Via
MarketBeat
Is Johnson & Johnson Stock Outperforming the Nasdaq?
February 24, 2026
Via
Barchart.com
Topics
Stocks
World Trade
Kenvue Defies Market Headwinds with Q4 Earnings Beat as Kimberly-Clark Merger Looms
February 23, 2026
Via
MarketMinute
Topics
Earnings
Economy
World Trade
Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio
↗
February 22, 2026
Via
The Motley Fool
Topics
Retirement
The Only Healthcare Stock I'd Buy and Never Sell Might Be Johnson & Johnson
↗
February 22, 2026
Via
The Motley Fool
Economic Stagnation: Q4 2025 GDP Misses Mark as Government Shutdown Hangs Heavy Over 2026 Outlook
February 20, 2026
Via
MarketMinute
Topics
Earnings
Economy
Friday's session: gap up and gap down stock in the S&P500 index
↗
February 20, 2026
Via
Chartmill
JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B
↗
February 19, 2026
Via
Stocktwits
Health Care Sector (XLV) Shows Resilience Amid Tech Volatility and Strong Jobs Data
February 18, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Earnings
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
February 18, 2026
From
Johnson & Johnson
Via
Business Wire
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer
↗
February 18, 2026
Via
Benzinga
Behind the Scenes of Johnson & Johnson's Latest Options Trends
↗
February 17, 2026
Via
Benzinga
Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner
↗
February 17, 2026
Via
Benzinga
Frequently Asked Questions
Is Johnson & Johnson publicly traded?
Yes, Johnson & Johnson is publicly traded.
What exchange does Johnson & Johnson trade on?
Johnson & Johnson trades on the New York Stock Exchange
What is the ticker symbol for Johnson & Johnson?
The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange
What is the current price of Johnson & Johnson?
The current price of Johnson & Johnson is 240.40
When was Johnson & Johnson last traded?
The last trade of Johnson & Johnson was at 03/06/26 07:00 PM ET
What is the market capitalization of Johnson & Johnson?
The market capitalization of Johnson & Johnson is 631.93B
How many shares of Johnson & Johnson are outstanding?
Johnson & Johnson has 632B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.